ERK1/2 Pathway-Mediated Differentiation of IGF-1-Transfected Spinal Cord-Derived Neural Stem Cells into Oligodendrocytes
Open Access
- 27 August 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (8) , e106038
Abstract
Spinal cord injury (SCI) is a devastating event that causes substantial morbidity and mortality, for which no fully restorative treatments are available. Stem cells transplantation offers some promise in the restoration of neurological function but with limitations. Insulin-like growth factor 1 (IGF-1) is a well-appreciated neuroprotective factor that is involved with various aspects of neural cells. Herein, the IGF-1 gene was introduced into spinal cord-derived neural stem cells (NSCs) and expressed steadily. The IGF-1-transfected NSCs exhibited higher viability and were promoted to differentiate into oligodendrocytes. Moreover, the most possible underlying mechanism, through which IGF-1 exerted its neuroprotective effects, was investigated. The result revealed that the differentiation was mediated by the IGF-1 activated extracellular signal-regulated kinases 1 and 2 (ERK1/2) and its downstream pathway. These findings provide the evidence for revealing the therapeutic merits of IGF-1-modified NSCs for SCI.Keywords
This publication has 38 references indexed in Scilit:
- Extracellular signal‐regulated kinase 1/2 signaling promotes oligodendrocyte myelination in vitroJournal of Neurochemistry, 2012
- Timing of Decompressive Surgery of Spinal Cord after Traumatic Spinal Cord Injury: An Evidence-Based Examination of Pre-Clinical and Clinical StudiesJournal of Neurotrauma, 2011
- Oligodendrocyte Fate after Spinal Cord InjuryNeurotherapeutics, 2011
- Spinal Cord Injury: A Systematic Review of Current Treatment OptionsClinical Orthopaedics and Related Research, 2010
- Molecular Genetic Advances in Neurological Disease: Special Review IssueHuman Molecular Genetics, 2010
- Modulation of the microenvironment by growth factors regulates the in vivo growth of skeletal myoblastsBJU International, 2009
- Gene transfer of insulin-like growth factor–I providing neuroprotection after spinal cord injury in ratsJournal of Neurosurgery: Spine, 2007
- Insulin‐like growth factor 1 is essential for normal dendritic growthJournal of Neuroscience Research, 2003
- Mammalian Neural Stem CellsScience, 2000
- Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitisLife Sciences, 1996